JUVENILE IDIOPATHIC INFLAMMATORY MYOPATHY (JIIM)

Clinical trials for JUVENILE IDIOPATHIC INFLAMMATORY MYOPATHY (JIIM) explained in plain language.

Never miss a new study

Get alerted when new JUVENILE IDIOPATHIC INFLAMMATORY MYOPATHY (JIIM) trials appear

Sign up with your email to follow new studies for JUVENILE IDIOPATHIC INFLAMMATORY MYOPATHY (JIIM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

One-Shot cell therapy aims to reset immune system in devastating muscle diseases

Disease control Recruiting now

This study is testing a one-time cell therapy called CABA-201 for adults and children with rare autoimmune diseases that cause severe muscle weakness and inflammation. The goal is to see if this treatment can safely reduce disease activity and improve muscle strength, potentially…

Matched conditions: JUVENILE IDIOPATHIC INFLAMMATORY MYOPATHY (JIIM)

Phase: PHASE2, PHASE3 • Sponsor: Cabaletta Bio • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

JUVENILE IDIOPATHIC INFLAMMATORY MYOPATHY (JIIM)

Get alerted when new JUVENILE IDIOPATHIC INFLAMMATORY MYOPATHY (JIIM) trials appear

One-Shot cell therapy aims to reset immune system in devastating muscle diseases